00799nam0-22002771i-450-9900036888004033212000101088-7179-097-9000368880FED01000368880(Aleph)000368880FED0100036888020000920d--------km-y0itay50------baitay-------001yy<<La >>Borsa di MilanoDalle origini a Palazzo Mezzanottetesti di Ezio Antonini, Gianni Mezzanotte, Anna Maria Galli ed altriMilanoFederico Mottac1993190 p.Antonini,EzioITUNINARICAUNIMARCBK990003688800403321SE114.01.29-4664DECSEDECSEBorsa di Milano500110UNINA00957nam0-22003491i-450-99000066691040332120090609125252.0000066691FED01000066691(Aleph)000066691FED0100006669120090609d1960----km-y0itay50------bafreCHy-------001yyLe Corbusier 1910-60[publié par] Willy Boesiger, Elsa GirsbergerZurichEditions Girsberger1960334 p.ill.24 cmLe Corbusier (Charles Edouard Jeanneret)720.944720.23Boesiger,WillyGirsberger,ElsaITUNINARICAUNIMARCBK99000066691040332101 DA 30031649DINST13 D 74 0224107FINBCDINSTFINBCLe Corbusier 1910-60326254UNINA02746nam 2200613 450 991079041870332120230803021710.01-118-47334-51-118-47330-21-118-47337-X(CKB)2550000001115767(EBL)1376942(OCoLC)857969529(MiAaPQ)EBC1376942(DLC) 2013019255(Au-PeEL)EBL1376942(CaPaEBR)ebr10756810(CaONFJC)MIL516102(EXLCZ)99255000000111576720130506h20132013 uy| 0engur|n|---|||||rdacontentrdamediardacarrierBlood and marrow transplantation long-term management prevention and complications /edited by Bipin N. SavaniChichester, West Sussex, UK :John Wiley & Sons,[2013]©20131 online resource (416 p.)Description based upon print version of record.1-118-47340-X 1-299-84851-6 Includes bibliographical references and index.section 1. Late effects concepts -- section 2. Management -- section 3. Supportive care for long-term survivors after HSCT. Currently more than 100,000 patients undergo blood and marrow transplantation (BMT) annually worldwide, a number which is steadily increasing. Long-term survival after BMT has improved significantly since its inception over 40 years ago, due to improved supportive care and early recognition of long-term complications. With broadening indications, more options for BMT, and improvement in survival, by 2020 there may be up to a million long-term survivors after BMT globally. Higher than average rates of second malignancies and cardiopulmonary, infectious, endocrine, and renal diseases, and bonHematopoietic stem cellsTransplantationBone marrowTransplantationHematopoietic stem cellsTransplantationComplicationsBone marrowTransplantationComplicationsLong-term care of the sickHematopoietic stem cellsTransplantation.Bone marrowTransplantation.Hematopoietic stem cellsTransplantationComplications.Bone marrowTransplantationComplications.Long-term care of the sick.616.02/774Savani Bipin N1468891MiAaPQMiAaPQMiAaPQBOOK9910790418703321Blood and marrow transplantation long-term management3680256UNINA